Familial Combined Hyperlipidemia

A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (UPSTREAM STIMULATORY FACTORS) on CHROMOSOME 1.

Also Known As:

Combined Hyperlipidemia, Familial; Hyperlipidemia, Familial Combined; Combined Hyperlipidemias, Familial; Familial Combined Hyperlipidemias; Hyperlipidemia, Multiple Lipoprotein Type; Hyperlipidemias, Familial Combined; Hyperlipidemias, Multiple Lipoprotein-Type; Lipoprotein-Type Hyperlipidemia, Multiple; Lipoprotein-Type Hyperlipidemias, Multiple; Multiple Lipoprotein-Type Hyperlipidemia; Multiple Lipoprotein-Type Hyperlipidemias; Hyperlipidemia, Multiple Lipoprotein-Type

Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 960
- Inborn Genetic Diseases: 12342
  - Inborn Errors Metabolism: 1183
    - Inborn Errors Lipid Metabolism
      - Familial Combined Hyperlipidemia: 375
Nutritional and Metabolic Diseases: 15
- Metabolic Diseases: 10634
  - Inborn Errors Metabolism: 1183
    - Inborn Errors Lipid Metabolism
      - Familial Combined Hyperlipidemia: 375
  - Lipid Metabolism Disorders: 987
    - Dyslipidemias: 18780
      - Hyperlipidemias: 16526
        Familial Combined Hyperlipidemia: 375
    - Inborn Errors Lipid Metabolism
      - Familial Combined Hyperlipidemia: 375

Cristina García-Ulloa Selected Research

Cristina García-Ulloa Research Topics

Disease

Drug/Important Bio-Agent (IBA)